|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0056 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/401 | (2013.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 31/401 | (2006.01) | ||
| A61K 31/405 | (2013.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61K 31/4172 | (2013.01) | ||
| A61K 31/4172 | (2006.01) | ||
| A23L 33/175 | (2016.08) | ||
| A23L 33/175 | (2016.01) | ||
| A61K 33/00 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/1635 | (2013.01) | ||
| A21D 2/24 | (2006.01) | ||
| A61K 9/205 | (2013.01) | ||
| A23L 33/16 | (2016.01) | ||
| A61K 9/5073 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A23L 33/15 | (2016.08) | ||
| A23L 33/15 | (2016.01) | ||
| A23L 33/16 | (2016.08) | ||
| A61K 33/00 | (2006.01) | ||
| A21D 2/245 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61K 31/00 | (2013.01) |
| (11) | Number of the document | 4129270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22178328.5 |
| Date of filing the European patent application | 2016-09-27 | |
| (97) | Date of publication of the European application | 2023-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201562233695 P | 2015-09-28 | US |
| (72) |
REINER, Alberto , IT
REINER, Giorgio , IT
|
| (73) |
APR APPLIED PHARMA RESEARCH S.A. ,
Via Corti 5, 6828 Balerna,
CH
|
| (54) | MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS |
| MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS |